Peter Chen

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 2

Top Topics

Combination Therapy

Decision Making

Top Venues

PharmacoEconomics

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Adrian R Levy, Peter Chen, Karissa M Johnston, Yan Wang, Evan Popoff, Ioannis Tomazos
Quantifying the economic effects of ravulizumab versus eculizumab treatment in patients with atypical hemolytic uremic syndrome. Journal of medical economics 25 (1) (2022)
Kate Williams, Daniel Aggio, Peter Chen, Katerina Anokhina, Andrew J Lloyd, Yan Wang
Utility Values Associated with Atypical Hemolytic Uremic Syndrome-Related Attributes: A Discrete Choice Experiment in Five Countries. PharmacoEconomics 39 (8) (2021)